共 50 条
- [31] New MRI contrast agents based on silicon nanotubes loaded with superparamagnetic iron oxide nanoparticles ROYAL SOCIETY OPEN SCIENCE, 2018, 5 (08):
- [32] Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 7073 - 7075
- [34] CARS microscopy for the visualization of micrometer-sized iron oxide MRI contrast agents in living cells BIOMEDICAL OPTICS EXPRESS, 2011, 2 (09): : 2470 - 2483
- [36] Liposomes Loaded with Hydrophobic Iron Oxide Nanoparticles: Suitable T2 Contrast Agents for MRI INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (08):
- [39] Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 465 - 481
- [40] Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes Reply DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 7076 - 7078